CRISPR KNOCKOUT OF TAX1BP3 REDUCES EXPRESSION OF P53 IN HUMAN PAPILLOMA NEGATIVE AND HUMAN PAPILLOMA POSITIVE CERVICAL CARCINOMA CELLS.

- Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, El Gomhouria Street, Dakahlia Governorate, Egypt.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Mansoura University, El Gomhouria Street, Dakahlia Governorate, Egypt.
- School of Cancer and Imaging Science, Research Floor, St Mary's Hospital, Hathersage Road, Manchester M13 0JH. UK.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Background: The PDZ protein Tax 1 binding protein 3 (Tax1BP3) is unique since, unlike other PDZ proteins, it contains a single rather than multiple PDZ domains. Previous work has shown Tax1BP3 is a target of oncoproteins from two separate human tumor viruses and it is known to regulate Rho and wnt/β-catenin signaling. Most importantly Tax1BP3 has been shown to promote degradation of the p53 protein in glioma cells although it is not clear whether it performs this same function in tumor virus positive cell types . Methods: The cervical cancer cell lines C33A (HPV negative), C33AE6 (HPV16 E6 transfected) and CaSki (HPV16 positive) were stably transfected with a CRISPR/Cas9 Tax1BP3 knockout construct. Levels of Tax1BP3 mRNA were initially determined in puromycin resistant monoclonal cells by RT-PCR. Tax1BP3 and p53 protein levels were then analyzed by a combination of western immunoblotting and flow cytometry. Results: Both bi and monoallelic Tax1BP3 targeted cell lines were isolated for all three cell types which showed either partial or complete silencing of Tax1BP3 expression. Irrespective of cell type, all cells which had reduced or absent Tax1BP3 expression showed much lower levels of p53 protein than control cells.. Conclusion: Unlike previous findings with glioma cells, the presented data showed that reduced levels of Tax1BP3 directly correlated with reduced levels of p53 protein expression. Furthermore, this effect was seen in cells whether or not they expressed mutant (C33A) or wild type (CaSki) p53 or full or partial HPV genome (CaSki and C33AE6). These results suggest that Tax1BP3 regulates p53 protein levels in HPV positive and negative cells by a novel and non-canonical means.
- Ainsworth, J., Thomas, M., Banks, L., Coutlee, F., &Matlashewski, G. (2008). Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.?Virology journal,?5(1), 67.
- Alewine, C., Olsen, O., Wade, J. B., & Welling, P. A. (2006). TIP-1 has PDZ scaffold antagonist activity.?Molecular biology of the cell,?17(10), 4200-4211.
- Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., ...& Zhang, F. (2013). Multiplex genome engineering using CRISPR/Cas systems.?Science,?339(6121), 819-823.
- Ebina, H., Misawa, N., Kanemura, Y., &Koyanagi, Y. (2013). Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.?Scientific reports,?3.
- Gaj, T., Gersbach, C. A., &Barbas, C. F. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.?Trends in biotechnology,?31(7), 397-405.
- Gu, B., & Zhu, W. G. (2012). Surf the post-translational modification network of p53 regulation.?International journal of biological sciences,?8(5), 672.
- Wang, J., He, X., Luo, Y., & Yarbrough, W. G. (2006). A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.?Biochemical Journal,?393(2), 489-501.
- Hampson, L., Li, C., Oliver, A. W., Kitchener, H. C., &Hampson, I. N. (2004). The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein.?International journal of oncology,?25(5), 1249-1256.
- Han, M., Wang, H., Zhang, H. T., & Han, Z. (2012). The PDZ protein TIP-1 facilitates cell migration and pulmonary metastasis of human invasive breast cancer cells in athymic mice.?Biochemical and biophysical research communications,?422(1), 139-145.
- Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., ...& Mo, X. (2014). RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.?Proceedings of the National Academy of Sciences,?111(31), 11461-11466..
- Kanamori, M., Sandy, P., Marzinotto, S., Benetti, R., Kai, C., Hayashizaki, Y., ...& Suzuki, H. (2003). The PDZ protein tax-interacting protein-1 inhibits β-catenin transcriptional activity and growth of colorectal cancer cells.?Journal of Biological Chemistry,?278(40), 38758-38764.
- Katoh, M., &Katoh, M. (2007). WNT signaling pathway and stem cell signaling network.?Clinical cancer research,?13(14), 4042-4045.
- Lin, S. R., Yang, H. C., Kuo, Y. T., Liu, C. J., Yang, T. Y., Sung, K. C., ... & Wu, F. Y. (2014). The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo.?Molecular Therapy-Nucleic Acids,?3, e186.
- Lowy, A. M., Clements, W. M., Bishop, J., Kong, L., Bonney, T., Sisco, K., ...&Groden, J. (2006). β-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.?Cancer research,?66(9), 4734-4741.
- Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., ...& Church, G. M. (2013). RNA-guided human genome engineering via Cas9.?Science,?339(6121), 823-826.
- Mohanty, S., Ovee, M., & Banerjee, M. (2015). pdz domain recognition: insight from human tax-interacting protein 1 (TIP-1) interaction with target proteins.?Biology,?4(1), 88-103.
- Olalla, L., Aledo, J. C., Bannenberg, G., &M?rquez, J. (2001). The C‐terminus of human glutaminase L mediates association with PDZ domain‐containing proteins 1.?FEBS letters,?488(3), 116-122.
- Oliver, A. W., He, X., Borthwick, K., Donne, A. J., Hampson, L., &Hampson, I. N. (2011). The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42.?British journal of cancer,?104(2), 324.
- Ran, F. A., Hsu, P. D., Lin, C. Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., ... & Zhang, F. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.?Cell,?154(6), 1380-1389.
- Reynaud, C., Fabre, S., &Jalinot, P. (2000). The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element.?Journal of Biological Chemistry,?275(43), 33962-33968.
- Rousset, R., Fabre, S., Desbois, C., Bantignies, F., &Jalinot, P. (1998). The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins.?Oncogene,?16(5).
- Shalaby, M. A., Hampson, L., Oliver, A., &Hampson, I. (2011). Identification of PlexinD1 and AHDC1 as a putative interactors for Tip-1 protein.?Genes & Genomics,?33(4), 399-405.
- Wang, H., Han, M., WhetsellJr, W., Wang, J., Rich, J., Hallahan, D., & Han, Z. (2014). Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.?Oncogene,?33(12), 1558.
- Xiao-Jie, L., Hui-Ying, X., Zun-Ping, K., Jin-Lian, C., & Li-Juan, J. (2015). CRISPR-Cas9: a new and promising player in gene therapy.?Journal of medical genetics, jmedgenet-2014.
- Yan, H., Kapoor, V., Nguyen, K., Akers, W. J., Li, H., Scott, J., ... &Hallahan, D. (2016). Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers.?Oncotarget,?7(28), 43352.
- Zencir, S., Banerjee, M., Dobson, M. J., Ayaydin, F., Fodor, E. A., Topcu, Z., &Mohanty, S. (2013). New partner proteins containing novel internal recognition motif for human glutaminase interacting protein (hGIP).?Biochemical and biophysical research communications,?432(1), 10-15.
- Zhen, S., Hua, L., Takahashi, Y., Narita, S., Liu, Y. H., & Li, Y. (2014). In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9.?Biochemical and biophysical research communications,?450(4), 1422-1426.
[Mona El Helaly El Sherbeny, Hussein Abdelaziz Abdalla, El Said Mohamed Abd El Hady, Ian Noel Hampson, Anthony.W.Oliver, Souad Mohamed Abo Azma and Muhamad Muhamad Said. (2017); CRISPR KNOCKOUT OF TAX1BP3 REDUCES EXPRESSION OF P53 IN HUMAN PAPILLOMA NEGATIVE AND HUMAN PAPILLOMA POSITIVE CERVICAL CARCINOMA CELLS. Int. J. of Adv. Res. 5 (Aug). 1402-1411] (ISSN 2320-5407). www.journalijar.com
Mansoura university, Faculty of Medicine, Medical biochemistry and molecular biology department, El Gomhouria Street, Dakahlia Governorate , Egypt